Cytek earnings
WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry … WebFounded 1992 Status Public Employees 583 Stock Symbol CTKB Investments 4 Share Price $8.75 (As of Thursday Closing) General Information Description Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.
Cytek earnings
Did you know?
WebFeb 28, 2024 · Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This … WebFeb 28, 2024 · Cytek Biosciences, Inc. provided earnings guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, …
WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry median of 32.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. WebApr 11, 2024 · Cytek Biosciences (NASDAQ:CTKB) has a market capitalization of $1.22 billion and generates $164.04 million in revenue each year. The company earns $2.58 …
WebAug 11, 2024 · Q2: 2024-08-10 Earnings Summary Press Release EPS of $0.03 misses by $0.01 Revenue of $40.16M (32.07% Y/Y) beats by $530.00K Cytek Biosciences, Inc. ( NASDAQ: CTKB) Q2 2024 Earnings... WebApr 11, 2024 · The Zacks Consensus Estimate for Encompass Health’s 2024 earnings is pegged at $3.07 per share, indicating a 7.7% increase from the prior-year reported figure. The consensus mark for 2024...
WebSep 30, 2024 · Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the third quarter 2024 financial results on Wednesday, November 9, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
WebApr 12, 2024 · All earnings call transcripts on Cytek Biosciences, Inc. (CTKB) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides. philip kingsley hair quizWebNov 11, 2024 · Cytek Biosciences ( NASDAQ:CTKB) Third Quarter 2024 Results Key Financial Results Revenue: US$40.5m (up 18% from 3Q 2024). Net income: US$1.67m (up 382% from 3Q 2024). Profit margin: 4.1% (up... philip kingsley hair clinicWebApr 12, 2024 · Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript SA Transcripts Sat, Nov. 12, 2024 Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2024 Results Earnings Call Transcript... philip kingsley hair tabletsWebFeb 28, 2024 · Cytek Biosciences, Inc. provided earnings guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. philip kingsley hair loss clinicWebFeb 28, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers … philip kingsley hair thickenerWebCytek's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 955.5M. Over the last four quarters, Cytek's revenue has grown by 176.8%. … philip kingsley hair thinningWebNov 8, 2024 · Cytek Biosciences, Inc. ( NASDAQ: CTKB) Q3 2024 Earnings Conference Call November 8, 2024 4:30 PM ET Company Participants Wenbin Jiang - Chief Executive Officer Patrik Jeanmonod - Chief... philip kingsley hair tonic